Answers are grounded in this paper and cite their sources.
Murraya koenigii essential oil (MKEO) was extracted from pre-processed leaves by hydro-distillation following sonication pre-treatment, and its yield and bio-efficacy were evaluated. Sonication facilitates cell-wall disruption and essential oil release, with 40 min identified as the optimum pre-treatment time. The extracted MKEO was incorporated into a nanoemulsion (MKEONE) and evaluated for biological activities. MKEO exhibited broad-spectrum antimicrobial activity against Escherichia coli (12.0 ± 0.3 mm) and Staphylococcus aureus (14.0 ± 0.2 mm), whereas MKEONE selectively inhibited S. aureus (12.0 ± 0.4 mm; MIC 96 µL). MKEO and MKEONE showed DPPH radical-scavenging activity (IC50 139.34 ± 0.08 and 300 ± 0.08 µL, respectively) and inhibited lipid peroxidation (TBARS IC50 78.61 ± 0.0009 and 113.96 ± 0.00198 µL, respectively). MKEONE exhibited LPL inhibition (IC50 158 ± 0.005 µL). Both samples upregulated PRDM16 expression in 3T3-L1 adipocytes by 3.64- and 2.73-fold, respectively, comparable to Orlistat (p > 0.05) under the tested conditions.
No takes yet. Share an insight, caveat, or question.
Govindaraju et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: